Consolidated Statements of Net Loss - USD ($)		12 Months Ended
		Dec. 31, 2022	Dec. 31, 2021
Revenue		$ 1,505,459	$ 1,420,680
Cost of sales		505,107	487,024
Gross profit		1,000,352	933,656
General and administrative expense		11,110,735	10,932,125
Operations expense		3,798,425	2,698,565
Sales and marketing expense		1,358,907	774,530
Loss on goodwill impairment		7,231,093	2,813,792
Loss on impairment of intangibles		3,349,375	2,893,548
Loss on long-lived tangible asset impairment		185,469	1,249,727
Total operating loss		(26,033,652)	(20,428,631)
Other income		185,646	184,528
Other expense		(5,275)	(239,631)
Gain on derivative instruments		115,647	164,902
Loss before income tax benefit		(25,737,634)	(20,318,832)
Benefit from release of valuation allowance		0	(661,658)
Net loss		$ (25,737,634)	$ (19,657,174)
Loss per common share - basic and diluted (in dollars per share)		$ (0.35)	$ (0.36)
Weighted average shares used in computation - basic and diluted (in shares)	[1]	72,997,987	54,876,044

[1] The following is a summary of the number of underlying shares outstanding at the end of the respective periods that have been excluded from the diluted calculations because the effect on loss per common share would have been anti-dilutive: Year Ended December 31, 2022 2021 Options 981,060 1,062,871 RSUs 83,334 366,667 Warrants 36,328,731 31,699,885 Preferred stock: Series B 79,246 79,246